In an acute promyelocytic leukemia model, elevated tumor-derived PGD2 and NKp30-B7H6 engagement was found to activate ILC2s, which in turn drove the activation of M-MDSCs via IL-13 secretion [143]. Here, IL13 is linked to neoplasm.